Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder-Reference-Cited by-同舟云学术

Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder

Published:2021-08-12 Issue:6 Volume:15 Page:2000058
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Wang Yi¹²,Liu Xinxin¹,Liu Dan¹,Cheng Mengchun¹,Zhao Nan¹,He Meixi¹²,Zhang Xiaozhe¹^ORCID

Affiliation:

1. CAS Key Laboratory of Separation Science for Analytical Chemistry Dalian Institute of Chemical Physics Chinese Academy of Sciences 457 Zhongshan Road Dalian China

2. University of Chinese Academy of Sciences Beijing PR China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.202000058

Reference34 articles.

1. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies

2. The diagnosis of depression: current and emerging methods

3. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review;Macdonald K.;American Journal of Medical Genetics,2019

4. Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders

5. A preliminary analysis of association between plasma microRNA expression alteration and symptomatology improvement in Major Depressive Disorder (MDD) patients before and after antidepressant treatment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular formula assignment of dissolved organic matter by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry using two non-targeted data processing approaches: A case study from recirculating aquaculture systems;Analytica Chimica Acta;2024-02

2. Discovery and validation of protein biomarkers for monitoring the effectiveness of drug treatment for major depressive disorder;Journal of Psychiatric Research;2024-01

3. Peptides as “better biomarkers”? Value, challenges, and potential solutions to facilitate implementation;Mass Spectrometry Reviews;2023-06-26

4. Post-translational Modifications in Brain Diseases: A Future for Biomarkers;Advances in Experimental Medicine and Biology;2022